Gene Marcial
  • Market Alert: Pluristem (PSTI) New Indication in Heart Disease… May 18, 2012 by Ray Dirks
    Pluristem Therapeutics' (PSTI) Platform Technology Shows Promise in Large New Clinical Indication: Heart Disease By Ray Dirks New Indication May Boost Company Valuation Tuesday, PSTI revealed preclinical data showing that its platform technology, PLX cells, is effective in a type of heart disease that has no current cures. The condition is known as diabetic diastolic dysfunction, a subset of diastolic heart disease that occurs when one or both ventricles of the heart suffer in performance, leading to heart failure....

    Read More »

© 2012 CP Reports · Disclaimer · Subscribe:PostsComments · Designed by Theme Junkie · Powered by WordPress